Patent Expiry

Patent/Exclusivity Expiry: BYVALSON

Other upcoming events for ANIP

Phase 3 ReadoutPhase 3 Topline: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Af
Patent ExpiryPatent/Exclusivity Expiry: OXTELLAR XR
Patent ExpiryPatent/Exclusivity Expiry: OPFOLDA
Patent ExpiryPatent/Exclusivity Expiry: LOREEV XR

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Patent/Exclusivity Expiry: BYVALSON — ANIP Patent Expiry | BioSniper